Data as of Q4 2025 (Dec 31, 2025)
โณ
Showing Q3 2025 data
New Leaf Venture Partners, L.L.C.'s Q4 2025 filing not yet available. Expected by Feb 14, 2026.

New Leaf Venture Partners, L.L.C.

โ€ขCIK: 1631614โ€ขFiling: Q3 2025

**New Leaf Venture Partners, L.L.C.** manages $43M across a concentrated portfolio of 7 positions. The fund exhibits significant conviction in its top holdings, notably allocating $16.7M to EWTX and $13.5M to ARVN. Further substantial exposure is maintained in CRNX at $5.9M, followed by COGT at $3.6M. This structure suggests a targeted, high-conviction approach within its investment mandate.

Total AUM
$43.0M
QoQ Performance
-18.7%
Positions
7
Top 10 Concentration
100.0%
Latest Filing
Q3 2025

Top Holdings Allocation

EWTX
ARVN
CRNX
COGT
EWTX38.8%
ARVN31.4%
CRNX13.6%
COGT8.4%
RLYB3.8%
ALEC2.3%
PASG1.6%

๐Ÿ“ˆ Biggest Buys

No new positions or increases this quarter

๐Ÿ“‰ Biggest Sells

โ€”
PASG
-96.5%
1.6% of portfolio

Sector Breakdown

Other100.0%

๐Ÿšช Exited Positionssold since Q2 2025

โ€”
ITERUM THERAPEUTICS PLC
SOLD
$343.3K

Changes from Q2 2025

โ†“1 decreased

Historical Filings

Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023